|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 31/70 | (2006.01) |
| (11) | Number of the document | 3254675 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17181174.8 |
| Date of filing the European patent application | 2010-02-12 | |
| (97) | Date of publication of the European application | 2017-12-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation | 2019-06-25 |
| (30) | Number | Date | Country code |
| 152608 P | 2009-02-13 | US |
| (72) |
ZHANG, Jiang, US
MEYER, Colin J., US
|
| (73) |
Reata Pharmaceuticals Holdings, LLC,
5320 Legacy Drive, Plano, TX 75024,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sulėtinto atpalaidavimo peroralinio vartojimo kompozicijos, kurių sudėtyje yra amorfinis CDDO-Me |
| DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME |
| Payment date | Validity (years) | Amount | |
| 2025-01-22 | 16 | 347.00 EUR |
| 2026-02-12 |